Search results

Evidence-based recommendations on irreversible electroporation (IRE) for treating renal cancer. This involves using electrical pulses to kill cancer cells, applied directly to the tumour through special needles.

Result type

HealthTech guidance

Published

23 February 2013

Evidence-based recommendations on high-intensity focused ultrasound for treating prostate cancer. This involves inserting a probe through the rectum that gives out a beam of ultrasound to heat and destroy the cancerous prostate tissue.

Result type

HealthTech guidance

Published

23 March 2005

Discontinued Reference number: GID-TA10259

Result type

Technology appraisal guidance

Status

Discontinued

Discontinued Reference number: GID-TA10698

Result type

Technology appraisal guidance

Status

Discontinued

Discontinued Reference number: GID-TA11041

Result type

Technology appraisal guidance

Status

Discontinued

Discontinued Reference number: GID-TA11000

Result type

Technology appraisal guidance

Status

Discontinued

Discontinued Reference number: GID-TAG526

Result type

Technology appraisal guidance

Status

Discontinued

Evidence-based recommendations on melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver. This involves diverting the blood flow from the liver to the rest of the body while the drug is delivered directly into the liver.

Result type

HealthTech guidance

Published

21 April 2021

Discontinued Reference number: GID-TA10927

Result type

Technology appraisal guidance

Status

Discontinued

Discontinued Reference number: GID-TA10634

Result type

Technology appraisal guidance

Status

Discontinued

Evidence-based recommendations on endoscopic radiofrequency ablation for Barrett’s oesophagus with low-grade dysplasia or no dysplasia. This involves using radiofrequency (heat) energy to destroy the abnormal cells and promote the growth of healthy normal cells.

Result type

HealthTech guidance

Published

23 July 2014

Evidence-based recommendations on pembrolizumab (Keytruda) for previously treated endometrial, biliary, colorectal, gastric or small intestine cancer with high microsatellite instability or mismatch repair deficiency in adults.

Result type

Technology appraisal guidance

Published

20 September 2023

Evidence-based recommendations on brachytherapy as the sole method of adjuvant radiotherapy for breast cancer after local excision. This involves inserting radioactive sources into the space in the breast where tissue has been removed to minimise the chances of the cancer coming back.

Result type

HealthTech guidance

Published

23 July 2008

Discontinued Reference number: GID-TAG398

Result type

Technology appraisal guidance

Status

Discontinued

Evidence-based recommendations on sofosbuvir (Sovaldi) for treating some types of chronic hepatitis C (HCV)

Result type

Technology appraisal guidance

Published

25 February 2015